Efficacy and safety of anti-PD-1 antibody plus regorafenib in refractory microsatellite stable metastatic colorectal cancer: a retrospective single-arm cohort study

• Published in: Annals of translational medicine Vol. 10; no. 16; p. 880
• Main Authors: Li, Rong-Rong, Yin, Xian-Li, Zeng, De-Yu, Shao, Feng-Jiang, Yamamoto, Seiichiro, Liu, Wu, Liu, Zhen-Yang
• Format: Journal Article
• Language: English
• Published: AME Publishing Company 01.08.2022
• Subjects: Original

BackgroundManagements for refractory proficient mismatch repair (pMMR) or microsatellite stable (MSS) metastatic colorectal cancer (mCRC) were still challenging and controversial. Our study sought to investigate the efficacy and safety of anti-programmed cell death protein 1 (anti-PD-1) antibodies p...